27-hydroxycholesterol has been researched along with Airflow Obstruction, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Hashimoto, Y; Hoshikawa, Y; Ichikawa, T; Ichinose, M; Kikuchi, T; Koarai, A; Numakura, T; Okada, Y; Okazaki, T; Onodera, K; Sato, K; Sugiura, H; Tamada, T; Tanaka, R; Togo, S; Yamada, M; Yanagisawa, S | 1 |
| Akamatsu, K; Furukawa, K; Hirano, T; Ichikawa, T; Ichinose, M; Kawabata, H; Kikuchi, T; Koarai, A; Matsunaga, K; Minakata, Y; Nakanishi, M; Sugiura, H; Yanagisawa, S | 1 |
2 other study(ies) available for 27-hydroxycholesterol and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
27-Hydroxycholesterol accelerates cellular senescence in human lung resident cells.
Topics: Cell Line; Cell Proliferation; Cellular Senescence; Cholestanetriol 26-Monooxygenase; Cyclin-Dependent Kinase Inhibitor p16; Epithelial Cells; Fibroblasts; Humans; Hydroxycholesterols; Lung; Macrophages, Alveolar; Pulmonary Disease, Chronic Obstructive; Reactive Nitrogen Species; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |
Increase of 27-hydroxycholesterol in the airways of patients with COPD: possible role of 27-hydroxycholesterol in tissue fibrosis.
Topics: Aged; Bronchi; Case-Control Studies; Cell Culture Techniques; Cholestanetriol 26-Monooxygenase; Extracellular Matrix Proteins; Female; Fibroblasts; Fibrosis; Forced Expiratory Volume; Humans; Hydroxycholesterols; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Sputum; Vital Capacity | 2012 |